Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 100.0%
August 31, 2026 100.0%
July 31, 2026 100.0%
June 30, 2026 100.0%
May 31, 2026 100.0%
April 30, 2026 100.0%
March 31, 2026 100.0%
February 28, 2026 100.0%
January 31, 2026 100.0%
December 31, 2025 100.0%
November 30, 2025 100.0%
October 31, 2025 100.0%
September 30, 2025 100.0%
August 31, 2025 100.0%
July 31, 2025 100.0%
June 30, 2025 100.00%
May 31, 2025 100.00%
April 30, 2025 99.93%
March 31, 2025 99.93%
February 28, 2025 99.93%
January 31, 2025 99.93%
December 31, 2024 99.93%
November 30, 2024 99.93%
October 31, 2024 99.93%
September 30, 2024 99.93%
Date Value
August 31, 2024 99.93%
July 31, 2024 99.92%
June 30, 2024 99.91%
May 31, 2024 99.89%
April 30, 2024 99.60%
March 31, 2024 99.55%
February 29, 2024 99.55%
January 31, 2024 99.55%
December 31, 2023 99.55%
November 30, 2023 99.55%
October 31, 2023 98.76%
September 30, 2023 98.76%
August 31, 2023 98.72%
July 31, 2023 98.70%
June 30, 2023 98.70%
May 31, 2023 98.70%
April 30, 2023 98.70%
March 31, 2023 98.70%
February 28, 2023 98.70%
January 31, 2023 98.70%
December 31, 2022 98.70%
November 30, 2022 98.70%
October 31, 2022 98.70%
September 30, 2022 98.70%
August 31, 2022 98.70%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Dynatronics Corp. 100.0%
Urologix, Inc. 100.00%
Medite Cancer Diagnostics Inc 100.00%
Viveve Medical, Inc. 100.0%
Hemagen Diagnostics, Inc. 100.00%